Jump to content

Trypanosomiasis

From Wikipedia, the free encyclopedia
Trypanosomiasis
SpecialtyInfectious diseases, veterinary medicine Edit this on Wikidata

Trypanosomiasis or trypanosomosis is the name of several diseases in vertebrates caused by parasitic protozoan trypanosomes of the genus Trypanosoma. In humans this includes African trypanosomiasis and Chagas disease. A number of other diseases occur in other animals.

African trypanosomiasis, which is caused by either Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense, threatens some 65 million people in sub-Saharan Africa, especially in rural areas and populations disrupted by war or poverty. The number of cases has been going down due to systematic eradication efforts: in 1998 almost 40,000 cases were reported but almost 300,000 cases were suspected to have occurred; in 2009, the number dropped below 10,000; and in 2018 it dropped below 1000.[1] Chagas disease causes 21,000 deaths per year mainly in Latin America.[2]

Signs and symptoms

[edit]

The tsetse fly bite erupts into a red chancre sore and within a few weeks, the person can experience fever, swollen lymph glands, blood in urine, aching muscles and joints, headaches and irritability. In the first phase, the patient has only intermittent bouts of fever with lymphadenopathy together with other non-specific signs and symptoms. The second stage of the disease is marked by involvement of the central nervous system with extensive neurological effects like changes in personality, alteration of the biological clock (the circadian rhythm), confusion, slurred speech, seizures and difficulty in walking and talking. These problems can develop over many years and if not treated, the person dies. It is common in Subsaharan Africa.

Diagnosis

[edit]

Cattle may show enlarged lymph nodes and internal organs. Haemolytic anaemia is a characteristic sign. Systemic disease and reproductive wastage are common, and cattle appear to waste away.

Horses with dourine show signs of ventral and genital edema and urticaria.

Infected dogs and cats may show severe systemic signs.

Diagnosis relies on recognition of the flagellate on a blood smear. Motile organisms may be visible in the buffy coat when a blood sample is spun down. Serological testing is also common.

One common way in which trypanosomiasis can be diagnosed in humans is through the detection of antibodies against trypanosomes made by host organisms.[3] One commonly used antibody test which operated based on this principle is the card agglutination test, C.A.T.T. for T. gambiense.[3][4] In this test, reagent is mixed with blood and shaken. Within a matter of minutes, a researcher or public health professional can determine whether someone has made these antibodies and therefore is infected with trypanosomes.[5] Regarding the accuracy of this test, it is reported to have an 87 to 98 percent sensitivity rating.[3]

Another way to diagnose trypanosomiasis in humans is to detect the trypanosome protozoans themselves.[3] One way to do this would be to use lymph node aspirate. In this test, which has a sensitivity of between 40 and 80 percent, a healthcare worker will first find a cervical lymph node which is enlarged.[3][6] Once the healthcare worker has punctured that lymph node, its aspirate is examined under a microscope for trypanosomes to confirm diagnosis.[3]

Prevention

[edit]

The use of trypanotolerant breeds for livestock farming should be considered if the disease is widespread. Fly control is another option but is difficult to implement. The main approaches to controlling African trypanosomiasis are to reduce the reservoirs of infection and the presence of the tsetse fly. Screening of people at risk helps identify patients at an early stage. Diagnosis should be made as early as possible and before the advanced stage to avoid complicated, difficult and risky treatment procedures.[citation needed]

Treatment

[edit]

Stage I of the condition is usually treated with pentamidine or suramin through intramuscular injection or intravenous infusion if sufficient observation is possible. Stage II of the disease is typically treated with melarsoprol or eflornithine preferably introduced to the body intravenously. Both pentamidine and suramin have limited side effects. Melarsoprol is extremely effective but has many serious side effects which can cause neurological damage to a patient, however, the drug is often a patient's last hope in many late stage cases. Eflornithine is extremely expensive but has side effects that may be treated with ease.[7] In regions of the world where the disease is common eflornithine is provided for free by the World Health Organization.[citation needed]

Epidemiology

[edit]

Trypanosomes and trypanosomiasis disease is transmitted through the tsetse fly. As many as 90 percent of sleeping sickness cases are caused by the Glossina fuscipes subspecies of the fly.[8] The palpalis subspecies contributes the majority of the rest of the cases. The different subspecies of fly dominate different habitats. For instance, the Glossina Morsitans subspecies inhabits savannahs while the Glossina Palpalis subspecies prefers woody riverine habitats.[9] However, all flies are susceptible to extremes in temperature (outside of the 16-40 degree Celsius range). Furthermore, trypanosomes are only able to reproduce in tsetse flies between the 25 to 30 Celsius range. These factors mean that only a minority of tsetse flies, around 20 percent, are estimated to carry trypanosomes.[9] These flies can also adapt to human activity, thus causing changes in disease patterns. For example, when brush is cleared for agriculture, the flies can retreat into the savannah and conversely when humans move into brush, the flies will reproduce and feed more frequently.[10] As a result, large increases of population associated with expansion into woody habitats often coincides with trypanosomiasis epidemics.[10]

Traditionally, cattle herders in East Africa were well aware of the effects of the tsetse flies and avoided these areas or set fire to the bush in order to clear the area of the flies and infected animals. The equilibrium was disturbed in the colonial era leading to multiple epidemics.[11]

Humans, their livestock, or wild animals can all act as reservoirs of trypanosomiasis disease.[10] However, the reservoirs used differ based on subspecies of trypanosoma protozoans and thus the variants of trypanosomiasis disease. There are two main variants of trypanosomoiasis which are in turn transmitted by different subspecies of the trypanosome protozoans.[12] Trypanosoma brucei rhodiense tends to result in more acute forms of disease and is mainly transmitted form one human to another. Most patients with this variant of disease will die within six months of infection.[13] Cattle can also act as a reservoir in areas where disease incidence is lower.[10] Trypanosoma brucei gambiense is the second type of protozoan which usually results in more chronic disease patterns.[12] Its main reservoir is the cattle populations. Although it is also fatal, death can take months or years to occur.[14] Geographical separation of these two variants of trypanosomes occurs along the Rift Valley. Trypanosoma brucei rhodiense is usually found on the eastern side of the valley while the gambiense variant resides on the western side.[8] The ranges of the two disease variants could overlap in Uganda, Tanzania, and Congo in the future.[15]  

Trypanosomiasis case numbers reported to the WHO from 2000-2013. Data used came from Franco, J. R., Simarro, P. P., Diarra, A., & Jannin, J. G. (2014). Epidemiology of human African trypanosomiasis. Clinical epidemiology, 257-275.[15]

Research

[edit]

Trypanosomiasis could, in future be prevented by genetically altering the tsetse fly. As the tsetse fly is the main vector of transmission, making the fly immune to the disease by altering its genome could be the main component in an effort to eradicate the disease. New technologies such as CRISPR allowing cheaper and easier genetic engineering could allow for such measures.[citation needed] A pilot program in Senegal, funded by the International Atomic Energy Agency, has considerably reduced the tsetse fly population by introducing male flies which have been sterilized by exposure to gamma rays.[16] This has allowed a change of cattle breeds from lower producing trypanotolerant breeds to higher-producing foreign breeds, and was selected as one of the Best Sustainable Development Practices on Food Security by EXPO Milan 2015.[17]

Other animals

[edit]
Chagas endemic zones (in red)

Some species of cattle such as the African buffalo, N'dama, and Keteku appear trypanotolerant and do not develop symptoms. Calves are more resistant than adults.[citation needed]

Tsetse-borne species of trypanosomes have entered zoos outside the traditional tsetse zone in infected animals imported for the zoo.[18][19]

References

[edit]
  1. ^ WHO. "Trypanosomiasis, Human African (sleeping sickness)". Fact sheet N°259. World Health Organization. Retrieved 25 February 2014.
  2. ^ Maya JD, Cassels BK, Iturriaga-Vásquez P, et al. (2007). "Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host". Comp. Biochem. Physiol. A. 146 (4): 601–20. doi:10.1016/j.cbpa.2006.03.004. PMID 16626984.
  3. ^ a b c d e f Chappuis, François; Loutan, Louis; Simarro, Pere; Lejon, Veerle; Büscher, Philippe (January 2005). "Options for Field Diagnosis of Human African Trypanosomiasis". Clinical Microbiology Reviews. 18 (1): 133–146. doi:10.1128/CMR.18.1.133-146.2005. ISSN 0893-8512. PMC 544181. PMID 15653823.
  4. ^ Mitashi, Patrick; Hasker, Epco; Lejon, Veerle; Kande, Victor; Muyembe, Jean-Jacques; Lutumba, Pascal; Boelaert, Marleen (2012-11-29). "Human African Trypanosomiasis Diagnosis in First-Line Health Services of Endemic Countries, a Systematic Review". PLOS Neglected Tropical Diseases. 6 (11): e1919. doi:10.1371/journal.pntd.0001919. ISSN 1935-2735. PMC 3510092. PMID 23209860.
  5. ^ Bonnet, Julien; Boudot, Clotilde; Courtioux, Bertrand (2015-10-04). "Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?". BioMed Research International. 2015: e583262. doi:10.1155/2015/583262. ISSN 2314-6133. PMC 4609347. PMID 26504815.
  6. ^ Vanhecke, C; Guevart, E; Ezzedine, K; Receveur, M-C; Jamonneau, V; Bucheton, B; Camara, M; Vincendeau, P; Malvy, D (2010-02-01). "[Human African trypanosomiasis in mangrove epidemiologic area. Presentation, diagnosis and treatment in Guinea, 2005-2007]". Pathologie-biologie. 58 (1): 110–116. doi:10.1016/j.patbio.2009.07.033. ISSN 1768-3114. PMID 19854583.
  7. ^ Oxford Textbook of Medicine (Forth ed.). New York: Oxford University Press. 2003. pp. 770, 771.
  8. ^ a b Kargbo, Alpha; Kuye, Rex A. (2020-06-19). "Epidemiology of tsetse flies in the transmission of trypanosomiasis: technical review of The Gambia experience". International Journal of Biological and Chemical Sciences. 14 (3): 1093–1102. doi:10.4314/ijbcs.v14i3.35. ISSN 1997-342X.
  9. ^ a b Jordan, A M (December 1979). "Trypanosomiasis control and land use in Africa". Outlook on Agriculture. 10 (3): 123–129. doi:10.1177/003072707901000304. ISSN 0030-7270. S2CID 155470767.
  10. ^ a b c d Arden., Hoppe, Kirk (2003). Lords of the fly : sleeping sickness control in British East Africa, 1900-1960. Praeger. ISBN 0-325-07123-3. OCLC 51216398.{{cite book}}: CS1 maint: multiple names: authors list (link)
  11. ^ Headrick, Daniel R. (April 24, 2014). "Sleeping Sickness Epidemics and Colonial Responses in East and Central Africa, 1900–1940". PLoS Negl Trop Dis 8(4): e2772.
  12. ^ a b "CDC - African Trypanosomiasis - Biology". www.cdc.gov. 2020-03-09. Retrieved 2023-02-28.
  13. ^ Odiit, M.; Kansiime, F.; Enyaru, J. C. (December 1997). "Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda". East African Medical Journal. 74 (12): 792–795. ISSN 0012-835X. PMID 9557424.
  14. ^ Pépin, J.; Méda, H. A. (2001). "The epidemiology and control of human African trypanosomiasis". Advances in Parasitology. 49: 71–132. doi:10.1016/s0065-308x(01)49038-5. ISBN 978-0-12-031749-3. ISSN 0065-308X. PMID 11461032.
  15. ^ a b Franco, Jose R.; Simarro, Pere P.; Diarra, Abdoulaye; Jannin, Jean G. (2014). "Epidemiology of human African trypanosomiasis". Clinical Epidemiology. 6: 257–275. doi:10.2147/CLEP.S39728. ISSN 1179-1349. PMC 4130665. PMID 25125985.
  16. ^ Paquette, Danielle (2019-05-31). "A U.S.-funded nuclear project to zap a killer fly into extinction is saving West Africa's cows". The Washington Post. Retrieved 2019-06-01.
  17. ^ "The Tsetse Fly Eradication Project in Senegal Wins Award for Best Sustainable Development Practices". IAEA. 23 July 2015. Retrieved 2021-11-16.
  18. ^ Mbaya, A. W.; Aliyu, M. M.; Ibrahim, U. I. (2009-04-02). "The clinico-pathology and mechanisms of trypanosomosis in captive and free-living wild animals: A review". Veterinary Research Communications. 33 (7). Springer: 793–809. doi:10.1007/s11259-009-9214-7. ISSN 0165-7380. PMID 19340600.
  19. ^ Adler, Peter H.; Tuten, Holly C.; Nelder, Mark P. (2011-01-07). "Arthropods of Medicoveterinary Importance in Zoos". Annual Review of Entomology. 56 (1). Annual Reviews: 123–142. doi:10.1146/annurev-ento-120709-144741. ISSN 0066-4170. PMID 20731604.

Bibliography

[edit]
  • Thomas, H Wolferstan (1905). Report on trypanosomes, trypanosomiasis, and sleeping sickness : being an experimental investigation into their pathology and treatment. London: University Press of Liverpool. OCLC 11692559.
  • Manson, Patrick (1914). Tropical diseases : a manual of diseases of warm climates (5th ed.). New York: William Wood. OCLC 812165069.
  • Daniels, Charles Wilberforce (1914). Tropical Medicine and Hygiene. New York. OCLC 810109334.{{cite book}}: CS1 maint: location missing publisher (link)
  • Maudlin, Ian; Holmes, Peter; Miles, Michael W (2004). The trypanosomiases. Wallingford, UK; Cambridge, Massachusetts: CABI Publishing. ISBN 9780851990347. OCLC 58543155.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Trypanosomiasis&oldid=1248505946"